Latest Capital Raises News

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Euroz Hartleys Group Limited reported a robust 87.7% increase in net profit for FY25, driven by growth across brokerage, underwriting, and wealth management. The company declared a fully franked full-year dividend of 5.5 cents per share, reflecting confidence in its operational leverage and balance sheet strength.

The Takeovers Panel has declined to investigate alleged breaches related to Yowie Group’s recent share placement and funding arrangements, finding no material impact on company control or disclosure issues.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

Harmoney has delivered a robust FY25 performance, exceeding its upgraded profit guidance with strong loan book growth and improved efficiency. The fintech lender projects a remarkable 111% increase in cash NPAT for FY26, driven by its AI-powered Stellare 2.0 platform and strategic expansion plans.

Astron Corporation has completed its redomicile from Hong Kong to Australia, launching Astron Limited (Aus NewCo) as the new ASX-listed parent company with a 2-for-1 share consolidation.

Straker Ltd reported a 10% revenue decline in FY25 but achieved record gross margins and adjusted EBITDA, underscoring its strategic shift to AI-driven language services and expanding IBM partnership.

Centaurus Metals Limited has updated the timetable for its $3 million Share Purchase Plan, offering eligible shareholders in Australia and New Zealand shares at $0.36 each with free-attaching options exercisable at $0.50.

Genetic Technologies Limited has emerged from voluntary administration following a strategic asset sale and is now pursuing recapitalisation and acquisitions to restore its market position.

LDR Assets Pty Ltd, part of the Lederer Family Office, has initiated an off-market takeover offer for all stapled securities in the Elanor Commercial Property Fund at a 5.3% premium to recent prices. The bid signals a potential overhaul of ECF’s management and governance.

Redcastle Resources Limited has resumed trading on the ASX following key announcements about a joint venture farm-out, a strategic placement, and a major gold project acquisition.

Redcastle Resources has partnered with BML Ventures to fast-track gold production at key deposits while massively expanding its Eastern Goldfields footprint through a strategic tenement acquisition.